A Prospective Active Surveillance Study to Monitor Growth, Development, and Maturation Among Adolescents with Atopic Dermatitis Exposed to Abrocitinib First published 14/04/2025 Last updated 22/04/2025 EU PAS number:EUPAS1000000515 Study Planned